Sodium Channel Blocker Cuts Post-Surgery Pain

The sodium channel blocker LTG-001, an investigational selective Nav1.8 inhibitor, reduced pain scores more than placebo for 2 days after abdominoplasty in a phase IIb trial. The primary endpoint was the time-weighted sum of pain scores.